Anti-NDFIP2 monoclonal antibody

Pre-made anti-NDFIP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NDFIP2/NDFIP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1244-Ab-1/ GM-Tg-hg-IP1244-Ab-2Anti-Human NDFIP2 monoclonal antibodyHuman
GM-Tg-rg-IP1244-Ab-1/ GM-Tg-rg-IP1244-Ab-2Anti-Rat NDFIP2 monoclonal antibodyRat
GM-Tg-mg-IP1244-Ab-1/ GM-Tg-mg-IP1244-Ab-2Anti-Mouse NDFIP2 monoclonal antibodyMouse
GM-Tg-cynog-IP1244-Ab-1/ GM-Tg-cynog-IP1244-Ab-2Anti-Cynomolgus/ Rhesus macaque NDFIP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1244-Ab-1/ GM-Tg-felg-IP1244-Ab-2Anti-Feline NDFIP2 monoclonal antibodyFeline
GM-Tg-cang-IP1244-Ab-1/ GM-Tg-cang-IP1244-Ab-2Anti-Canine NDFIP2 monoclonal antibodyCanine
GM-Tg-bovg-IP1244-Ab-1/ GM-Tg-bovg-IP1244-Ab-2Anti-Bovine NDFIP2 monoclonal antibodyBovine
GM-Tg-equg-IP1244-Ab-1/ GM-Tg-equg-IP1244-Ab-2Anti-Equine NDFIP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1244-Ab-1/ GM-Tg-hg-IP1244-Ab-2; GM-Tg-rg-IP1244-Ab-1/ GM-Tg-rg-IP1244-Ab-2;
GM-Tg-mg-IP1244-Ab-1/ GM-Tg-mg-IP1244-Ab-2; GM-Tg-cynog-IP1244-Ab-1/ GM-Tg-cynog-IP1244-Ab-2;
GM-Tg-felg-IP1244-Ab-1/ GM-Tg-felg-IP1244-Ab-2; GM-Tg-cang-IP1244-Ab-1/ GM-Tg-cang-IP1244-Ab-2;
GM-Tg-bovg-IP1244-Ab-1/ GM-Tg-bovg-IP1244-Ab-2; GM-Tg-equg-IP1244-Ab-1/ GM-Tg-equg-IP1244-Ab-2
Products NameAnti-NDFIP2 monoclonal antibody
Formatmab
Target NameNDFIP2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NDFIP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1244-Ag-1Recombinant multi-species NFIP2/ NDFIP2/ N4WBP5A protein
    ORF Viral VectorpGMLPm002097mouse Ndfip2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002097mouse Ndfip2 Lentivirus particle


    Target information

    Target IDGM-IP1244
    Target NameNDFIP2
    Gene ID54602,76273,361089,698464,476956,101090228,512310,100054516
    Gene Symbol and Synonyms0710001O20Rik,2810436B12Rik,9130207N19Rik,mKIAA1165,N4WBP5A,NDFIP2
    Uniprot AccessionQ9NV92
    Uniprot Entry NameNFIP2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102471
    Target ClassificationN/A

    The target: NDFIP2, gene name: NDFIP2, also named as N4WBP5A. Enables WW domain binding activity. Involved in negative regulation of gene expression; negative regulation of transport; and positive regulation of protein ubiquitination. Located in several cellular components, including Golgi apparatus; mitochondrion; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.